Rituximab® and high dose methylprednisolone (HDMP) as a first line treatment for patients with chronic lymphocytic leukemia

被引：0
|
作者：
Castro, JE
Bole, JE
Prada, CE
Loria, O
Kipps, TJ
机构：
[1] Univ Calif San Diego, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Chron Lymphocyt Leukemia Res Consortium, San Diego, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2969
引用
收藏
页码：833A / 833A
页数：1
相关论文
共 50 条
  • [21] High dose Rituximab in chronic lymphocytic leukemia.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    BLOOD, 2003, 102 (11) : 359B - 360B
  • [22] Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients
    Foa, Robin
    Del Giudice, Ilaria
    Cuneo, Antonio
    Del Poeta, Giovanni
    Ciolli, Stefania
    Di Raimondo, Francesco
    Lauria, Francesco
    Cencini, Emanuele
    Rigolin, Gian Matteo
    Cortelezzi, Agostino
    Nobile, Francesco
    Callea, Vincenzo
    Brugiatelli, Maura
    Massaia, Massimo
    Molica, Stefano
    Trentin, Livio
    Rizzi, Rita
    Specchia, Giorgina
    Di Serio, Francesca
    Orsucci, Lorella
    Ambrosetti, Achille
    Montillo, Marco
    Zinzani, Pier Luigi
    Ferrara, Felicetto
    Morabito, Fortunato
    Mura, Maria Angela
    Soriani, Silvia
    Peragine, Nadia
    Tavolaro, Simona
    Bonina, Silvia
    Marinelli, Marilisa
    De Propris, Maria Stefania
    Della Starza, Irene
    Piciocchi, Alfonso
    Alietti, Alessandra
    Runggaldier, Eva Josephine
    Gamba, Enrica
    Mauro, Francesca Romana
    Chiaretti, Sabina
    Guarini, Anna
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) : 480 - 486
  • [23] ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Lachaine, J.
    Kouroukis, C. T.
    VALUE IN HEALTH, 2016, 19 (03) : A248 - A248
  • [24] Immunochemotherapy with rituximab in combination with fludarabine and epirubicine as first-line treatment in patients with chronic lymphocytic leukemia
    Chow, K. U.
    Kim-Wanner, S.
    Hermann, S.
    Wunderle, L.
    Cordes, H. J.
    Bergmann, L., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] High-dose rituximab therapy in chronic lymphocytic leukemia
    Keating, M
    O'Brien, S
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 86 - 90
  • [26] High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy
    Dungarwalla, Moez
    Evans, Steve O.
    Riley, Unell
    Catovsky, Daniel
    Dearden, Clare E.
    Matutes, Estella
    HAEMATOLOGICA, 2008, 93 (03) : 475 - 476
  • [27] Chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) treatment with rituximab and high-dose methylprednisolone revisited
    Mata, Ana Vagos
    Espada, Eduardo
    Alves, Daniela Pereira
    Velosa, Fabiola
    Polo, Blanca
    Costa, Maria Joao
    Lopes, Conceicao
    Lacerda, Joao Forjaz
    Raposa, Joao Carlos
    LEUKEMIA & LYMPHOMA, 2020, 61 : 155 - 156
  • [28] FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RETROSPECTIVE STUDY
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Ionita, M.
    Calamar, D.
    Ionita, C. O.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 526 - 526
  • [29] Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
    Castro, Januario E.
    Choi, Michael Y.
    Carvajal, Tomas
    Li, Hongying
    James, Danelle Frances
    Messer, Karen
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Rituximab and High-Dose Methylprednisolone for the Initial Treatment of Chronic Lymphocytic Leukemia Is Associated with Promising Clinical Activity and Minimal Hematologic Toxicity
    James, Danelle F.
    Castro, Januario E.
    Sandoval-Sus, Jose David
    Jain, Sonia
    Bole, Janet
    Rassenti, Laura
    Kipps, Thomas J.
    BLOOD, 2008, 112 (11) : 24 - 24
12345